Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CUREVAC N.V.

(CVAC)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 09/24 02:48:26 pm
57.525 USD   -0.56%
09/23MODERNA : EU drugs regulator to decide on Pfizer vaccine booster in early October
RE
09/15Correction to CureVac 2nd Update Article on Sept. 14
DJ
09/15CureVac Cancels mRNA Contracts For COVID-19 Jab
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about CUREVAC N.V.
09/23MODERNA : EU drugs regulator to decide on Pfizer vaccine booster in early October
RE
09/15Correction to CureVac 2nd Update Article on Sept. 14
DJ
09/15CureVac Cancels mRNA Contracts For COVID-19 Jab
MT
09/14CUREVAC N : Contracts with manufacturing partners WACKER and Celonic terminated; Rentschle..
PU
09/14APPLE : U.S. stocks close lower on worries over recovery, corporate tax hikes
RE
09/14INTUIT : Wall Street dips as choppy recovery, looming tax hikes weigh on sentiment
RE
09/14CUREVAC N : Terminates Two Manufacturing Contracts Amid Streamlining of European mRNA Prod..
MT
09/14Health Care Stocks Rally Early Tuesday
MT
09/14CUREVAC N : Terminates 2 Manufacturing Contracts Amid Streamlining of European mRNA Produc..
MT
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
PU
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
EQ
09/14PRESS RELEASE : CureVac Streamlines European Network for mRNA Product Manufacturing
DJ
09/14CureVac Streamlines European Network for mRNA Product Manufacturing
CI
09/14CureVac Shares Fall Premarket on Termination of Vaccine Contracts With Wacker Chemie, C..
DJ
09/14CureVac Terminates Covid Vaccine Manufacturing Contract With Wacker Chemie, Celonic -- ..
DJ
08/31Health Care Stocks Add to Early Slide
MT
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet (Form 6-K)
PU
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet
PU
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet
EQ
08/31PRESS RELEASE : CureVac's CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lan..
DJ
08/31CureVac N.V.'s CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet
CI
08/30CUREVAC N : Preclinical Data Shows Sharp Reduction of Liver Fibrosis With mRNA Therapeutic..
MT
08/30CUREVAC N : Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRN..
PU
08/30CUREVAC N : Findings in preclinical mouse models provide first direct proof of efficacy of..
PU
08/30CUREVAC N : Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRN..
EQ
08/30PRESS RELEASE : CureVac Preclinical Data Demonstrates Significant Reduction of Liver Fibro..
DJ
08/30CureVac Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRNA..
CI
08/18CUREVAC N : Bionity - CureVac's Second-Generation Vaccine Candidate Demonstrates Improved ..
AQ
08/16CUREVAC N : GlaxoSmithKline's Next-Generation COVID-19 Vaccine Shows Improved Animal Immun..
MT
08/16CUREVAC N : Earnings Flash (CVAC) CUREVAC Posts Q2 Revenue EUR22.4M
MT
08/16GLAXOSMITHKLINE : GSK, CureVac's next-gen COVID-19 vaccine shows promise in monkey trial
RE
08/16SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Monday
MT
08/16GLAXOSMITHKLINE : CureVac's Second-Generation COVID-19 Vaccine Candidate Shows Potential i..
MT
08/16SECTOR UPDATE : Health Care
MT
08/16CUREVAC N : GlaxoSmithKline's Second-Generation COVID-19 Vaccine Candidate Shows Potential..
MT
08/16GLAXOSMITHKLINE : GSK, CureVac say their COVID-19 vaccine shows promise in monkey trial
RE
08/16CUREVAC N : Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improv..
PU
08/16CUREVAC N : Announces Financial Results for the Second Quarter and First Half of 2021 and ..
PU
08/16CUREVAC N : Announces Financial Results for the Second Quarter and First Half of 2021 and ..
PU
08/16Curevac N.V. Announces Unaudited Consolidated Financial Results for the Second Quarter ..
CI
08/16CureVac Announces that Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demon..
CI
08/16CUREVAC N : Announces Financial Results for the Second Quarter and First Half of 2021 and ..
EQ
08/16PRESS RELEASE : CureVac Announces Financial Results for the Second Quarter and First Half ..
DJ
08/16PRESS RELEASE : CureVac Announces Financial -2-
DJ
08/16PRESS RELEASE : CureVac Announces Financial -3-
DJ
08/16CUREVAC : Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved..
EQ
08/16PRESS RELEASE : CureVac : Second-Generation mRNA -2-
DJ
08/16PRESS RELEASE : CureVac : Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demon..
DJ
07/20EU begins real-time review of Sanofi-GSK COVID-19 vaccine
RE
07/05S.Korea in talks with mRNA vaccine makers to make up to 1 bln doses -govt official
RE
07/04S.Korea in talks with mRNA vaccine makers to make up to 1 bln doses -govt official
RE
07/01AFTER HOURS WATCH LIST SCORECARD : Usws, cvac
MT
07/01SECTOR UPDATE : Health Care Stocks Post Solid Gains Thursday
MT
07/01SECTOR UPDATE : Health Care Stocks Outpacing Most Other Sectors This Afternoon
MT
07/01GLOBAL MARKETS LIVE : Amazon, The Gap, Fod, Lockheed Martin, CureVac...
07/01SECTOR UPDATE : Health Care Stocks Steady Premarket Thursday
MT
07/01Wall Street Sees Narrowly Mixed Open; Weekly Jobless Claims Fall
MT
07/01EUROPEAN MIDDAY BRIEFING : Stocks Jump to Open -2-
DJ
07/01UPDATE : CureVac Tanks 13% as COVID-19 Jab Only 48% Effective in Final Analysis
MT
07/01CUREVAC : Berenberg reaffirms its Buy rating
MD
07/01CUREVAC N : COVID-19 Jab Only 48% Effective in Final Analysis
MT
07/01EMEA MORNING BRIEFING : Stocks to Advance But -2-
DJ
06/30MT NEWSWIRES AFTER HOURS WATCH LIST : Usws, cvac
MT
06/30CUREVAC N : COVID-19 Vaccine 48% Effective in Final Results From Key Trial; Shares Drop 10..
MT
06/30CureVac COVID-19 vaccine records only 48% efficacy in final trial readout
RE
06/30CUREVAC N : Unique pivotal study conducted in 10 countries in fast changing variant enviro..
PU
06/30CUREVAC N : Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidat..
PU
06/30CureVac N.V. Announces Results from the Final Analysis of its 40,000 Subject Internatio..
CI
06/30PRESS RELEASE : CureVac Final Data from Phase 2b/3 -2-
DJ
06/30PRESS RELEASE : CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vacc..
DJ
06/30CUREVAC N : Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidat..
EQ
06/30CureVac COVID-19 vaccine records only 48% efficacy in final trial readout
RE
06/30SECTOR UPDATE : Health Care Stocks Mostly Treading Water Near Wednesday Close
MT
06/30SECTOR UPDATE : Health Care Stocks Slip as Biotechs Rally
MT
06/30CureVac N.V. Announces Executive Changes
CI
1  2  3  4  5  6Next
Upcoming event on CUREVAC N.V.
11/09/21